Investor profile
Polaris Partners
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Polaris Partners is a Boston-based venture capital firm with nearly 30 years of experience backing transformational healthcare and biotech companies. The firm operates three specialized funds: a core venture fund focused on healthcare (digital health, consumer-centric businesses, patient/provider solutions, data science) and life sciences (molecules, platforms, therapeutics, genomics); a Polaris Growth Fund supporting profitable, founder-owned B2B software and technology-services companies with $4–20M revenue; and a Polaris Innovation Fund that accelerates the commercial and therapeutic potential of early-stage academic research. Polaris describes itself as 'not just investors' but 'builders'—board members, entrepreneurs, scientists, and operators who partner deeply with founders from seed through growth, with 150+ years of combined investment experience, 400+ companies funded, 100+ exits, and 60+ therapies brought to market.
Notable quotes
“Our firm divides its resources between healthcare and IT deals and writes checks from $50,000 to $60 million.”
“With Fund VI, we will continue our strategy of identifying compelling opportunities, investing early and closely partnering with great entrepreneurs and scientists.”
“The Polaris team not only creates great companies that change the world, but they go out of their way to treat everyone fairly—founders, employees and other investors. It's been a privilege to work with them.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Tavo Biotherapeutics | Series A | $17m | 2026-06-02 |
| EpiBiologics | Early Stage VC | — | 2025-10-31 |
| Zag Bio | Early Stage VC | — | 2025-10-25 |
| Auron Therapeutics | Early Stage VC | — | 2025-12-23 |
| Alnylam Pharmaceuticals | Early Stage VC | — | — |
| Akamai Technologies | Early Stage VC | — | — |
| Editas Medicine | Early Stage VC | — | — |
| Dyno Therapeutics | Seed/Early Stage VC | — | — |
| Dewpoint Therapeutics | Early Stage VC | — | — |
| Neumora Therapeutics | Early Stage VC | — | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| ARCH Venture Partners | 25 |
| GV (Google Ventures) | 10 |
| Invus | 6 |
| F-Prime Capital | 5 |
| Alexandria Venture Investments | 5 |
| RA Capital Management | 4 |
Fit check
Is Polaris Partners a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit